What Biotech Bubble? Specialty Pharma Stocks Pop Again on Merger Monday

March 31, 2015 2:08 PM

59 0

What Biotech Bubble? Specialty Pharma Stocks Pop Again on Merger Monday

M&A has helped drive the rally in biotech stocks in the past few years. And while many investors have grown concerned that valuations are getting too lofty, pharmaceutical companies showed that they remain willing to pay up for their targets.

The deals announced Monday show how M&A is both reshaping the pharmaceutical industry and rapidly responding to it. Midsize and large pharmaceutical companies have struggled to refill their product pipelines as many of their biggest cash-generating drugs come off patent.

Read more

To category page

Loading...